Clinical Trials of Texas, Inc. is a multi-specialty research organization in San Antonio. Qualified volunteers may receive an exam with a board certified physician, diagnostic testing and compensation for time and travel. Visit SAresearch.com to view our current studies.
Location: United States, Texas, San Antonio
Employees: 51-200
Phone: +1 210-949-0122
Founded date: 2001
Investors 1
| Date | Name | Website |
| 08.11.2021 | NMS Capita... | nms-capita... |
Mentions in press and media 11
| Date | Title | Description |
| 07.11.2024 | NMS Capital Exits Investment in Flourish Research | New York, NY, November 7, 2024 – NMS Capital (“NMS”), a leading private equity firm focused on investments within subsectors of Healthcare Services and Business Services, today announced that it has exited its investment in Flourish Researc... |
| 25.06.2024 | NMS Capital Portfolio Company Flourish Research Announces Partnership with ENCORE™ Research Group | New York, NY, June 25, 2024 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with ENCORE™ Research Group (“ENCORE” or the “Company”). ENCORE™ is a leading clinical research organiz... |
| 14.11.2023 | NMS Capital Portfolio Company Flourish Research Announces Partnership with Merritt Island Medical Research, Further Expanding Presence in Neuroscience | New York, NY, November 14, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with Merritt Island Medical Research (“MIMR” or the “Company”). MIMR is a leading clinical research... |
| 15.09.2023 | NMS Capital Portfolio Company Flourish Research Announces Partnership with Valley Clinical Trials Marking the Ninth Acquisition Since the Formation of Flourish in 2021 | New York, NY, September 15, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) is pleased to announce the acquisition of Valley Clinical Trials (“Valley” or the “Company”). Valley is a leading clinical research site... |
| 22.12.2022 | NMS Capital Portfolio Company Flourish Research Announces Partnership with Suncoast Research Group | New York, NY, December 16, 2022 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) is pleased to announce the acquisition of Suncoast Research Group, LLC (“Suncoast” or the “Company”). Suncoast is a leading, multi-therap... |
| 06.10.2022 | NMS Capital Portfolio Company Flourish Research Announces Partnership with Keystone Clinical Studies | New York, NY, October 6, 2022 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with company management in the recapitalization of Keystone Clinical Studies, LLC (“Keystone”). Keyst... |
| 22.02.2022 | Daniel Duffy Joins NMS Capital’s Operating Executive Council to Assist with Current and Future Investments in Outsourced Pharmaceutical Services | New York, NY, February 22, 2022 – NMS Capital (“NMS”), announced today a new executive partnership with Daniel Duffy to pursue platform investments in the outsourced pharmaceutical services industry, including clinical research, patient sup... |
| 12.01.2022 | NMS Capital Portfolio Company Flourish Research Announces Partnerships with Great Lakes Clinical Trials and Clinical Site Partners, Creating One of the Largest Clinical Site Networks in the United Sta... | New York, NY, January 12, 2022 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish” or the “Company”) announced today that it has partnered with company management in the recapitalizations of Great Lakes Clinical Trials (“G... |
| 14.10.2021 | NMS Capital Portfolio Company Flourish Research Announces Investment in Excel Medical Clinical Trials | New York, NY, October 14, 2021 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with company management in the recapitalization of Excel Medical Clinical Trials, LLC (“Excel”). Exc... |
| 12.08.2021 | NMS Capital Announces Formation of Flourish Research and Investment in Clinical Trials of Texas | New York, NY, August 12, 2021 – NMS Capital (“NMS”) announced today that it has formed Flourish Research (“Flourish”), which will aim to become a leading, nationwide network of clinical research sites with therapeutic area and clinical tria... |
Show more